MedTrace Logo

REM (Risk Of Endometrial Malignancy)

NCT01830192 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 741

Last updated 2013-04-12

No results posted yet for this study

Summary

The purpose of this study was to obtain a predictive model to asses the Risk of Endometrial Malignancy (REM) in women with ultrasound endometrial abnormalities.

Conditions

  • Endometrial Disease

Interventions

OTHER

Training set

We evaluate the clinical, ultrasound and laboratory features to predict endometrial cancer disease preoperative

OTHER

VERIFICATION SET

We evaluate the clinical, ultrasound and laboratory features to predict endometrial cancer disease preoperative

Sponsors & Collaborators

  • Campus Bio-Medico University

    lead OTHER

Principal Investigators

  • Roberto Angioli, MD · Campus Biomedico University of Rome

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-11-30
Completion
2012-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01830192 on ClinicalTrials.gov